- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent | 201 | PR Newswire | STOCKHOLM, Dec. 11, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, announces that it has been granted... ► Artikel lesen | |
| 05.12. | SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2 | 342 | PR Newswire | STOCKHOLM, Dec. 5, 2025 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") publishes an information document in connection with the offer to repurchase all outstanding... ► Artikel lesen | |
| 05.12. | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 193 | PR Newswire | STOCKHOLM, Dec. 5, 2025 /PRNewswire/ -- Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 05.12. | Scibase Holding AB: Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 206 | GlobeNewswire (Europe) | Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance with the proposal presented in the notice... ► Artikel lesen | |
| 21.11. | SCIBASE: The exercise price for warrants of series TO 3 has been determined | 2 | Cision News | ||
| 07.11. | SciBase: Interim report | 228 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ --
January 1 - September 30, 2025
The third quarter in figures
Net sales were TSEK 10,339 (8,408), +23%, cleared... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 07.11. | The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million | 271 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- The Board of Directors in SciBase Holding AB (publ) ("SciBase" or the "Company") has today resolved to make a repurchase offer for all 498,534... ► Artikel lesen | |
| 07.11. | SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million | 319 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that SciBase... ► Artikel lesen | |
| 22.10. | Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2026 | 220 | PR Newswire | STOCKHOLM, Oct. 22, 2025 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2026:
Anders... ► Artikel lesen | |
| 26.09. | SciBase: Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis | 309 | PR Newswire | STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication... ► Artikel lesen | |
| 23.09. | SciBase receives initial order for clinical study from Castle Biosciences | 323 | PR Newswire | STOCKHOLM, Sept. 23, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has... ► Artikel lesen | |
| 10.09. | Main owners strengthen their position in SciBase | 350 | PR Newswire | STOCKHOLM, Sept. 10, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that Ribbskottet... ► Artikel lesen | |
| 28.08. | SciBase: New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to Validating Nevisense | 329 | PR Newswire | STOCKHOLM, Aug. 28, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces the recent publication... ► Artikel lesen | |
| 19.08. | SciBase: Interim report | 389 | PR Newswire | STOCKHOLM, Aug. 19, 2025 /PRNewswire/ --
January 1 - June 30, 2025
The second quarter in figures
Net sales were TSEK 8,791 (6,641), +32%, cleared for currency effects +40%.The... ► Artikel lesen | |
| 01.08. | SciBase announces outcome in directed share issue | 425 | PR Newswire | STOCKHOLM, Aug. 1, 2025 /PRNewswire/ -- On 16 June 2025, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Company's Board of Directors resolved, pursuant to the authorisation... ► Artikel lesen | |
| 09.07. | SciBase Launches Nevisense Pilot at Leading University in Southeast Florida | 284 | PR Newswire | STOCKHOLM, July 9, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a... ► Artikel lesen | |
| 07.07. | SciBase: A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense. | 333 | PR Newswire | STOCKHOLM, July 7, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, is pleased to announce... ► Artikel lesen | |
| 30.06. | SciBase announces outcome in directed share issue | 233 | PR Newswire | STOCKHOLM, June 30, 2025 /PRNewswire/ -- On 23 June 2025, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Company's board of directors resolved, pursuant to the... ► Artikel lesen | |
| 23.06. | SciBase resolves on a directed share issue of approximately SEK 11 million | 365 | PR Newswire | STOCKHOLM, June 23, 2025 /PRNewswire/ -- The board of directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, in accordance with the intention published by the Company... ► Artikel lesen | |
| 17.06. | Bulletin from the annual general meeting in SciBase Holding AB (publ) | 453 | PR Newswire | STOCKHOLM, June 17, 2025 /PRNewswire/ -- Today, the annual general meeting 2025 has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 94,02 | -0,59 % | Streaming im Wandel: Warum sich bei Roku ein Blick lohnt und RTL+ und Joyn um Markanteile kämpfen. | Die Roku-Aktie hat seit Jahresbeginn bereits über 42?% zugelegt - Analysten wie Jefferies sehen dennoch weiteres Aufwärtspotenzial von bis zu 28?%. Während Roku mit Plattformwachstum und Kostenkontrolle... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,077 | -3,77 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 77,80 | -1,77 % | Boston Scientific transferring Galil Medical activity to Ireland | ||
| PAUL HARTMANN | 223,00 | -0,89 % | Januar bis September 2025: PAUL HARTMANN steigert Umsatz trotz schwächerer Absatzmärkte | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.826,0 Mio. EUR, organisches Umsatzwachstum von 2,0 % - Bereinigtes EBITDA liegt bei 195,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,7 % - Unternehmen... ► Artikel lesen | |
| SYSMEX | 8,500 | -0,58 % | Sysmex H1 Profit Declines | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex Corporation reported that its first half profit attributable to owners of the
parent was 19.0 billion yen, a decline of 26.9% from prior year. Earnings... ► Artikel lesen | |
| ADDLIFE | 16,130 | -0,86 % | AddLife AB: AddLife acquires Opitek International ApS | AddLife has acquired Opitek International ApS ("Opitek"), a manufacturer specializing in patient positioning. The company will become part of Mediplast, a company within AddLife's Business Area Medtech.AddLife... ► Artikel lesen | |
| EMBECTA | 10,200 | 0,00 % | Dividendenbekanntmachungen (05.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AGRICULTURAL BANK OF CHINA LTD CNE100000Q43 0,1195 CNY 0,0144 EUR AMERISAFE... ► Artikel lesen | |
| ENOVIS | 22,800 | +2,70 % | Enovis stock initiated with Buy rating at Freedom Capital Markets | ||
| PULMONX | 2,160 | +1,89 % | Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates | WASHINGTON (dpa-AFX) - Several healthcare and biotech stocks posted notable gains in after-hours trading on Monday, driven by earnings updates, executive appointments, and capital market activity.Pulmonx... ► Artikel lesen | |
| SI-BONE | 15,200 | 0,00 % | SI-BONE stock price target raised to $27 by Needham, named top pick for 2026 | ||
| KOOTH | 1,330 | -1,48 % | Kooth übernimmt US-Plattform für Kinder-Teletherapie | ||
| PEIJIA MEDICAL | 0,625 | -2,34 % | Peijia Medical Receives NMPA Approval for TaurusTrio Transcatheter Aortic Valve System, Pioneering Treatment for Aortic Regurgitation in China | HONG KONG, Dec. 12, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen | |
| LIFECARE ASA | 0,337 | -8,42 % | Lifecare ASA: Lifecare implants first consistently manufactured implant | ||
| BACTIGUARD | 1,445 | +7,04 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2025 | Continued profitability and clinical evidence supporting future growth
Third quarter 2025 (July - September)
Total revenue amounted to SEK 48.4 (73.9) million, a decrease of SEK 25.5 million corresponding... ► Artikel lesen | |
| PHC HOLDINGS | 5,750 | -0,86 % | PI Industries, Ltd.: PI AgSciences Integrates Plant Health Care (PHC) | ST. LOUIS, Nov. 24, 2025 /PRNewswire/ -- In August 2024, PI Industries Ltd. (PI) acquired Plant Health Care Plc (PHC), including subsidiaries in the U.S., Brazil, Mexico, and other markets.... ► Artikel lesen |
Das Unternehmen SCIBASE HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,006 Euro und damit -18,92 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.